Valuation Lundbeck Wiener Boerse

Stocks

End-of-day quote Wiener Boerse 2026-10-06			5-day change	1st Jan Change
5.780 ^EUR	+1.58%		+1.76%	+19.67%

09-25	H. Lundbeck A/S Relocates Its Us Headquarters from Deerfield, Illinois, to Greater Boston, Massachusetts	CI
09-25	Danish Biopharma Group H. Lundbeck to Relocate US Headquarters to Greater Boston	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	25,433	31,719	39,416	41,398	44,136	-	-
Change	-	24.72%	24.27%	5.03%	6.62%	-	-
Enterprise Value (EV) ¹	27,464	31,008	51,598	49,619	48,139	43,955	40,183
Change	-	12.91%	66.4%	-3.84%	-2.98%	-8.69%	-8.58%
P/E	13.5x	14.2x	13x	13.4x	9.93x	9.69x	10.2x
PBR	1.24x	1.47x	1.64x	1.72x	1.56x	1.4x	1.28x
PEG	-	0.7x	0.3x	8.5x	0.2x	4x	-1.92x
Capitalization / Revenue	1.39x	1.59x	1.79x	1.68x	1.71x	1.69x	1.73x
EV / Revenue	1.51x	1.56x	2.34x	2.01x	1.86x	1.68x	1.57x
EV / EBITDA	5.89x	5.49x	8.13x	6.3x	5.9x	5.31x	5.16x
EV / EBIT	9.63x	9.71x	15.8x	9.41x	7.87x	7.04x	6.83x
EV / FCF	10.2x	8.66x	18.7x	10.2x	8.21x	7.23x	7.19x
FCF Yield	9.83%	11.5%	5.35%	9.8%	12.2%	13.8%	13.9%
Dividend per Share ²	0.58	0.7	0.95	1.15	1.552	1.398	1.517
Rate of return	2.23%	2.14%	2.3%	2.66%	3.46%	3.12%	3.38%
EPS ²	1.93	2.31	3.17	3.22	4.519	4.628	4.383
Distribution rate	30.1%	30.3%	30%	35.7%	34.3%	30.2%	34.6%
Net sales ¹	18,246	19,912	22,004	24,630	25,871	26,102	25,543
EBITDA ¹	4,663	5,652	6,347	7,881	8,156	8,271	7,789
EBIT ¹	2,852	3,195	3,270	5,275	6,117	6,243	5,883
Net income ¹	1,916	2,290	3,143	3,192	4,567	4,619	4,293
Net Debt ¹	2,031	-711	12,182	8,221	4,003	-181.8	-3,953
Reference price ²	26.05	32.76	41.32	43.16	44.86	44.86	44.86
Nbr of stocks (in thousands)	992,840	992,840	992,011	991,227	991,227	-	-
Announcement Date	2/7/23	2/7/24	2/5/25	2/4/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.46x	11.79x	23.8x	0.61%	1,019B
JOHNSON & JOHNSON	28.13x	6.24x	17.86x	2.11%	610B
ABBVIE INC.	33.64x	7.86x	16.24x	2.61%	470B
MERCK & CO., INC.	101.52x	5.7x	24.22x	2.45%	344B
ROCHE HOLDING AG	18.95x	4.61x	11.45x	2.87%	336B
NOVARTIS AG	19.74x	5.16x	12.75x	3.1%	266B
ASTRAZENECA PLC	19.84x	4.13x	11.77x	2.15%	241B
AMGEN INC.	25.45x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.74x	6.39x	24.95x	2.28%	179B
Average	26.22x	6.50x	17.21x	2.3%	409.2B
Weighted average by Cap.	31.25x	7.60x	18.53x	1.96%